On Monday October 7 the Nobel Prize in Physiology or Medicine 2019 was awarded jointly to William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza "for their discoveries of how cells sense and adapt to oxygen availability."
In 1988 Sir Peter J. Ratcliffe and his team collaborated with Andrew Skinn (founder of Ruskinn Technology Ltd) with a vision to develop a precision control oxygen technology, which leaded to the launch of the first InvivO2 physoxic workstation. It is designed and built to mimic the physiology of the inner body tissue, giving the reassurance of precise results under controlled atmosphere conditions. It allows to study the most complex of cell interactions under precise physiological conditions, regulating and maintaining oxygen, carbon dioxide, temperature and humidity.
Today the InvivO2 and the bigger SCI-tive Workstations of Baker Ruskinn are further improved, high-tech tools in the research under physiological oxygen, as well as hypoxic or hyperoxic conditions of in-vitro cultured cells and tissues. The development of these workbenches is inspired by all researchers whose ideas led to new developments that have been integrated into this technology.